by Boston Web Design | May 11, 2026 | Research
SUMMARY Last month, the Drug Enforcement Administration moved to reschedule medical cannabis from Schedule I to Schedule III, setting the stage for a significant shift in the industry’s economic framework. The most consequential change would be the removal of Internal...
by Boston Web Design | Feb 10, 2026 | Research
SUMMARY Federal rescheduling, from Schedule I to III is a watershed moment. President Trump’s December 2025 executive order to move cannabis from Schedule I to Schedule III portends to be the most consequential federal cannabis action to date. It aligns federal policy...
by Boston Web Design | Sep 5, 2025 | Research
The inherent complexities and nuances of operating state-regulated cannabis businesses, forced to operate in closed economies, are costly and arguably excessive. This has continued since the Obama Administration gave the green light for adult use in 2012 (starting...
by Boston Web Design | Apr 8, 2025 | Research
Over the past 6 years (2019-2024), the Tier 1 Multistate Operators (MSOs) have generated $2.3B in Cash Flow from Operations; Assuming all unpaid 280E related tax liabilities are satisfied this amount is $1.3 Billion. ~$1B is owed in 280E related tax among 4 of the 5...
by Boston Web Design | Mar 21, 2025 | Research
“The business of America is business” ~ President Calvin Coolidge“The States are the laboratories of democracy” ~ SCOTUS Louis Brandies In 1996, Medical Marijuana was legalized in California during the Clinton Administration. Since the “Colorado...
by Boston Web Design | Nov 20, 2024 | Research
KEY POINTS: For over a decade, since the “Colorado experiment” in 2014, the Federal Government has maintained its prohibitive legal status of marijuana. Still, the pressures brought to bear by the multitude of state statutes that have locally decriminalized and...
